DEUTSCHE BANK AG\ - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 203 filers reported holding MYRIAD GENETICS INC in Q2 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$664,505
-26.1%
41,428
+6.8%
0.00%
Q2 2023$899,523
-38.1%
38,806
-38.0%
0.00%
-100.0%
Q1 2023$1,453,176
+23.4%
62,556
-22.9%
0.00%0.0%
Q4 2022$1,177,675
-12.4%
81,163
+15.3%
0.00%0.0%
Q3 2022$1,344,000
-6.1%
70,421
-10.5%
0.00%0.0%
Q2 2022$1,431,000
-61.0%
78,713
-45.9%
0.00%
-50.0%
Q1 2022$3,668,000
-10.7%
145,519
-2.3%
0.00%0.0%
Q4 2021$4,108,000
+48.2%
148,875
+73.4%
0.00%
+100.0%
Q3 2021$2,772,000
+4.6%
85,859
-0.9%
0.00%0.0%
Q2 2021$2,650,000
+0.9%
86,644
+0.5%
0.00%0.0%
Q1 2021$2,627,000
+36.0%
86,255
-11.7%
0.00%0.0%
Q4 2020$1,931,000
+75.7%
97,639
+15.8%
0.00%0.0%
Q3 2020$1,099,000
+61.4%
84,284
+40.3%
0.00%0.0%
Q2 2020$681,000
-82.6%
60,090
-78.0%
0.00%
-66.7%
Q1 2020$3,917,000
-94.7%
273,704
-89.9%
0.00%
-93.8%
Q4 2019$73,727,000
+2684.3%
2,707,626
+2824.5%
0.05%
+2300.0%
Q3 2019$2,648,000
-53.0%
92,585
-54.4%
0.00%
-33.3%
Q2 2019$5,632,000
+459.8%
202,852
+566.8%
0.00%
+200.0%
Q1 2019$1,006,000
-11.1%
30,421
-22.1%
0.00%0.0%
Q4 2018$1,132,000
-94.9%
39,041
-91.9%
0.00%
-83.3%
Q3 2018$22,230,000
+46.4%
483,322
+18.9%
0.01%
+50.0%
Q2 2018$15,187,000
+71.3%
406,453
+35.4%
0.00%0.0%
Q1 2018$8,865,000
+8.0%
300,171
+25.5%
0.00%
-20.0%
Q4 2017$8,209,000
-57.3%
239,151
-55.0%
0.01%
-61.5%
Q3 2017$19,230,000
+292.2%
531,617
+180.1%
0.01%
+225.0%
Q2 2017$4,903,000
+11.7%
189,829
-17.1%
0.00%
+33.3%
Q1 2017$4,391,000
-75.4%
228,901
-78.6%
0.00%
-78.6%
Q4 2016$17,864,000
-30.8%
1,071,771
-14.5%
0.01%
-22.2%
Q3 2016$25,804,000
+140.8%
1,253,978
+258.1%
0.02%
+125.0%
Q2 2016$10,714,000
+36.1%
350,217
+66.5%
0.01%
+33.3%
Q1 2016$7,872,000
+256.7%
210,374
+311.0%
0.01%
+200.0%
Q4 2015$2,207,000
+41.1%
51,181
+22.3%
0.00%
+100.0%
Q3 2015$1,564,000
-35.2%
41,860
-41.2%
0.00%
-50.0%
Q2 2015$2,414,000
+54.2%
71,157
+60.6%
0.00%
+100.0%
Q1 2015$1,566,000
-7.6%
44,301
-11.2%
0.00%0.0%
Q4 2014$1,695,000
-77.5%
49,893
-74.5%
0.00%
-80.0%
Q3 2014$7,545,000
+5.8%
195,743
+6.7%
0.01%0.0%
Q2 2014$7,133,000
-59.7%
183,375
-64.5%
0.01%
-61.5%
Q1 2014$17,680,000
+26.3%
517,233
-22.5%
0.01%
+30.0%
Q4 2013$13,995,000
-49.1%
667,488
-42.9%
0.01%
-50.0%
Q3 2013$27,470,0001,169,3220.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders